Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Antihypertensive Drugs Market
The global antihypertensive drugs market size valued at USD 23.9 billion in 2024 and is projected to exhibit 4.1% CAGR from 2025 to 2034. The market is growing due to growing prevalence of hypertension, advances in hypertensive drug development and formulations, growing awareness about the risks of hypertension, and integration of digital health solutions in treatment strategies.
Hypertension is a major global health issue, with a large portion of the population affected, especially in aging demographics. According to the World Health Organization, globally, approximately 1.28 billion adults aged 30 to 79 are living with hypertension. As the global population ages and lifestyles shift, hypertension rates continue to rise, creating a greater demand for antihypertensive medications. Moreover, with better healthcare infrastructure and awareness campaigns, more individuals are being diagnosed with hypertension. This is expected to contribute to an increasing number of patients seeking treatment, thus driving demand for antihypertensive drugs?.
Antihypertensive drugs are a class of drugs used to treat high blood pressure (hypertension). These medications help lower blood pressure by either relaxing the blood vessels or reducing the heart's workload, ultimately preventing complications such as stroke, heart attack, kidney damage, and other cardiovascular diseases.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Antihypertensive Drugs Market Size in 2024: | USD 23.9 Billion |
Forecast Period: | 2025 to 2034 |
Forecast Period 2025 to 2034 CAGR: | 4.1% |
2034 Value Projection: | USD 35.5 Billion |
Historical Data for: | 2021 – 2024 |
No. of Pages: | 140 |
Tables, Charts & Figures: | 171 |
Segments covered: | Therapy, Drug Type, Route of Administration, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|